Floatz logo

NEPENTHE

Pain

Bursa City HospitalSmall moleculePhase 4 / ApprovedActive
BBB
77/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
75/ 100
Competitive Position
81/ 100

Competitive context

43 Active assets in the Pain cohort.

Asset / SponsorPhaseRating
Tapentadol
Grünenthal GmbH
Phase 4BBB
Oxycodone
The First Affiliated Hospital with Nanjing Medical University
Phase 4BBB
Nabiximols
Jazz Pharmaceuticals
Phase 3BBB
FENTANYL
Aga Khan University
Phase 4BBB
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
University of Maryland, Baltimore
Phase 4BBB

View all 50 →

Same molecule, other indications

NEPENTHE is also rated in:

cancer of unknown primary siteDormant
BBB
Indicative ·
75 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →
AnalgesiaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →